Antitrypsin Deficiency News and Research

RSS
PPTA offers new DVD on plasma donation

PPTA offers new DVD on plasma donation

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Investigators receive two Alpha-1 Foundation grants for research on lung disorder

Investigators receive two Alpha-1 Foundation grants for research on lung disorder

Talecris announces publication of A1PI studies for AAT deficiency in Respiratory Research journal

Talecris announces publication of A1PI studies for AAT deficiency in Respiratory Research journal

New iPSC cell lines could help in treating patients with lung diseases

New iPSC cell lines could help in treating patients with lung diseases

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

Talecris Biotherapeutics announces 2010 eALTA award recipients

Talecris Biotherapeutics announces 2010 eALTA award recipients

FDA grants AGTC $1M for Phase II human clinical trial in alpha-1 antitrypsin deficiency

FDA grants AGTC $1M for Phase II human clinical trial in alpha-1 antitrypsin deficiency

Californians recognized for contributing to plasma protein lifesaving therapies

Californians recognized for contributing to plasma protein lifesaving therapies

Kamada, Baxter enter distribution and manufacturing agreement for Glassia Alpha-1 Antitrypsin Product

Kamada, Baxter enter distribution and manufacturing agreement for Glassia Alpha-1 Antitrypsin Product

Baxter announces definitive agreement with Kamada for GLASSIA alpha1-proteinase inhibitor

Baxter announces definitive agreement with Kamada for GLASSIA alpha1-proteinase inhibitor

Ingen Technologies' new SMART Nasal Cannula unveiled at Alpha-1 19th National Education Conference

Ingen Technologies' new SMART Nasal Cannula unveiled at Alpha-1 19th National Education Conference

Kamada commences enrollment in European inhaled AAT clinical trial for alpha-1 antitrypsin deficiency

Kamada commences enrollment in European inhaled AAT clinical trial for alpha-1 antitrypsin deficiency

Scientists identify new therapeutic approach for overcoming emphysema

Scientists identify new therapeutic approach for overcoming emphysema

Comparison study finds no significant differences in post-transplant survival rates of NASH and ETOH groups

Comparison study finds no significant differences in post-transplant survival rates of NASH and ETOH groups

Kamada finalizes agreement for the distribution of its intravenous alpha-1 antitrypsin in the United States

Kamada finalizes agreement for the distribution of its intravenous alpha-1 antitrypsin in the United States

New hope for sufferers of alpha-1 antitrypsin deficiency

New hope for sufferers of alpha-1 antitrypsin deficiency

Kamada reports positive data with inhaled Alpha-1 Antitrypsin in cystic fibrosis

Kamada reports positive data with inhaled Alpha-1 Antitrypsin in cystic fibrosis

Alpha1-antitrypsin deficiency associated with increased risk of lung cancer

Alpha1-antitrypsin deficiency associated with increased risk of lung cancer

Common gene disorder doubles risk of lung cancer, even among nonsmokers

Common gene disorder doubles risk of lung cancer, even among nonsmokers